Clinical Trial Update: Study of ARO-DM1 in Subjects With Type 1 Myotonic Dystrophy [Phase 1, Phase 2]

View source ↗

Summary

Ongoing Phase 1/2 clinical trial evaluating ARO-DM1 in subjects with Myotonic Dystrophy Type 1, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myotonic Dystrophy Type

Drugs mentioned

• ARO-DM1

Snippet

Sponsor: Arrowhead Pharmaceuticals | Conditions: Myotonic Dystrophy 1 | Phase 1, Phase 2 | Status: RECRUITING